CCM
BIOL

Consonance Capital Management’s Biolase, Inc. BIOL Stock Holding History

Consonance Capital Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-92
Closed -$1.12M – 22
2017
Q2 		$1.12M Sell
92
-9
-9% -$134K 0.13% 18
2017
Q1 		$1.7M Sell
101
-15
-13% -$272K 0.18% 22
2016
Q4 		$2.03M Sell
116
-27
-19% -$534K 0.22% 21
2016
Q3 		$3.13M Buy
143
+42
+42% +$748K 0.3% 21
2016
Q2 		$1.47M Buy
101
+1
+1% +$15.8K 0.21% 21
2016
Q1 		$1.64M Buy
100
+12
+14% +$151K 0.25% 20
2015
Q4 		$922K Sell
88
-4
-4% -$43.7K 0.12% 20
2015
Q3 		$1.04M Buy
92
+39
+74% +$725K 0.15% 25
2015
Q2 		$1.16M Buy
+53
New +$1.29M 0.12% 27

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $153M AUM 42.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $51.7M AUM 4.5% 1-Year Est. Return
TA
Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return